-

PQS by Innovaccer Receives NCQA Data Aggregator Validation Status, Earns Validated Data Stream Designation

The latest recognition reinforces PQS’ commitment to Data Integrity, Driving Seamless Interoperability for Better Outcomes

SAN FRANCISCO--(BUSINESS WIRE)--Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced that it has received the Validated Data Stream designation from the National Committee for Quality Assurance (NCQA) as part of its Data Aggregator Validation (DAV) program. PQS is among the latest cohort of vendors to earn this validation, which reflects the organization’s commitment to data quality, transparency, and interoperability.

This designation confirms that PQS’ data stream with community pharmacies meets NCQA’s rigorous standards enabling a seamless, report-ready flow of clinical data between pharmacies and payers, helping both sides improve care coordination and outcomes.

Data streams that earn validation undergo a rigorous, end-to-end assessment of the quality and integrity of data, and the procedures used to manage and safeguard it. From ingestion at primary sources through transmission to end users, validation verifies adherence to NCQA’s process, system, and data standards.

Validated data streams are uniquely accepted by NCQA as standard supplemental data in HEDIS® audits and do not require primary source verification for HEDIS® reporting. The DAV designation helps stakeholders save time and resources while increasing trust in aggregated data for quality improvement initiatives.

“This NCQA Data Aggregator Validation is a testament to PQS' commitment to fostering innovation and trust in pharmacies and their accessibility of data," said Todd Sega, Managing Director of Pharmacy for Innovaccer. "By ensuring the highest quality of clinical information, we are not only strengthening the foundation for value-based contracting, but also enabling pharmacies to play an even more central role in coordinated care, leading to healthier communities."

Validated data flows are a vital step in achieving NCQA's vision of a digital measurement ecosystem and improve the efficiency of today's quality measurement processes.

“This is an important milestone as we keep building a more connected healthcare ecosystem,” said Abhinav Shashank, CEO, Innovaccer. “With PQS and NCQA validation, we’re strengthening the foundation that pharmacies and health plans can build on together. It’s a significant step towards making care more collaborative, and ultimately, more effective.”

The NCQA DAV certification for PQS is effective immediately. To learn more about PQS’ validated data capabilities and partnership opportunities, visit pharmacyquality.com

About PQS by Innovaccer

PQS by Innovaccer aligns healthcare payers and pharmacies to achieve their shared goals of better patient outcomes and healthcare quality performance. As a neutral, trusted intermediary supporting the evolution of value-based care, PQS facilitates nationwide pharmacy-based care through our partners and the EQUIPP® platform. Utilizing deep clinical pharmacy knowledge and over a decade of performance management experience, we help clients develop strategies, implement quality improvement programs, and optimize the quality of healthcare for their populations served. For more information on how PQS can support you, please visit www.pharmacyquality.com.

Contacts

Press Contact:
Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-562-2139

Innovaccer Inc.


Release Versions

Contacts

Press Contact:
Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-562-2139

More News From Innovaccer Inc.

CMS Accepts Innovaccer for the ACCESS Model, Giving Health Systems a Zero-Risk Path to Medicare's Chronic Care Revolution

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer, a leading healthcare AI company, today announced that the Centers for Medicare & Medicaid Services (CMS) has accepted its application under Story Health Partners for the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, positioning the company for participation at the program's July 2026 launch. Innovaccer has been accepted across both Early Cardio-Kidney-Metabolic (eCKM) and Cardio-Kidney-Metabolic (CKM) tracks, spanning h...

BSIM Healthcare Services Adopts Innovaccer's AI Agents to Streamline Clinical Workflows and Enhance Patient Access

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced that BSIM Healthcare Services, a Washington, DC-based provider group, will implement Provider Copilot with Pre-Visit Summary, Ambient Scribing, Gravity’s Agentic AI Access Center, and Flow Auth for prior authorization automation. These additions follow successful deployments of Innovaccer's Gravity Platform and value-based care solutions. The implementation addresses administrative challenges acros...

Innovaccer and Infinia Technologies Form Strategic Alliance to Power the Future of AI-Driven Healthcare in the UAE

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, and Infinia Technologies, a next-generation digital transformation company and a subsidiary of Sirius International Holding under Abu Dhabi’s International Holding Company (IHC) Group, today announced a strategic alliance aimed at accelerating healthcare innovation across the United Arab Emirates. The alliance underscores a shared commitment to advancing a digital-first healthcare ecosystem in th...
Back to Newsroom